The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors

SHP2 promotes RAS-driven MAPK signalling, but it is unclear why cancer cells with distinct KRAS mutations exhibit differential sensitivity to SHP2 inhibition. Here the authors show that KRAS Q61H is decoupled from SHP2- mediated upstream regulation, thus Q61H pancreatic cancer cells maintain MAPK si...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Teklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, Nikolina Radulovich, Molly L. Udaskin, Ahmet Mentes, Richard Huang, Betty P. K. Poon, Wenguang He, Ivette Valencia-Sama, Claire M. Robinson, Melissa Huestis, Jinmin Miao, Jen Jen Yeh, Zhong-Yin Zhang, Meredith S. Irwin, Jeffrey E. Lee, Ming-Sound Tsao, Brian Raught, Christopher B. Marshall, Michael Ohh, Mitsuhiko Ikura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/adc5eaa39af340409424aef1fcf1144b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:adc5eaa39af340409424aef1fcf1144b
record_format dspace
spelling oai:doaj.org-article:adc5eaa39af340409424aef1fcf1144b2021-11-08T11:06:01ZThe Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors10.1038/s41467-021-26526-y2041-1723https://doaj.org/article/adc5eaa39af340409424aef1fcf1144b2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26526-yhttps://doaj.org/toc/2041-1723SHP2 promotes RAS-driven MAPK signalling, but it is unclear why cancer cells with distinct KRAS mutations exhibit differential sensitivity to SHP2 inhibition. Here the authors show that KRAS Q61H is decoupled from SHP2- mediated upstream regulation, thus Q61H pancreatic cancer cells maintain MAPK signalling and are refractory to SHP2 inhibitors.Teklab GebregiworgisYoshihito KanoJonathan St-GermainNikolina RadulovichMolly L. UdaskinAhmet MentesRichard HuangBetty P. K. PoonWenguang HeIvette Valencia-SamaClaire M. RobinsonMelissa HuestisJinmin MiaoJen Jen YehZhong-Yin ZhangMeredith S. IrwinJeffrey E. LeeMing-Sound TsaoBrian RaughtChristopher B. MarshallMichael OhhMitsuhiko IkuraNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Teklab Gebregiworgis
Yoshihito Kano
Jonathan St-Germain
Nikolina Radulovich
Molly L. Udaskin
Ahmet Mentes
Richard Huang
Betty P. K. Poon
Wenguang He
Ivette Valencia-Sama
Claire M. Robinson
Melissa Huestis
Jinmin Miao
Jen Jen Yeh
Zhong-Yin Zhang
Meredith S. Irwin
Jeffrey E. Lee
Ming-Sound Tsao
Brian Raught
Christopher B. Marshall
Michael Ohh
Mitsuhiko Ikura
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
description SHP2 promotes RAS-driven MAPK signalling, but it is unclear why cancer cells with distinct KRAS mutations exhibit differential sensitivity to SHP2 inhibition. Here the authors show that KRAS Q61H is decoupled from SHP2- mediated upstream regulation, thus Q61H pancreatic cancer cells maintain MAPK signalling and are refractory to SHP2 inhibitors.
format article
author Teklab Gebregiworgis
Yoshihito Kano
Jonathan St-Germain
Nikolina Radulovich
Molly L. Udaskin
Ahmet Mentes
Richard Huang
Betty P. K. Poon
Wenguang He
Ivette Valencia-Sama
Claire M. Robinson
Melissa Huestis
Jinmin Miao
Jen Jen Yeh
Zhong-Yin Zhang
Meredith S. Irwin
Jeffrey E. Lee
Ming-Sound Tsao
Brian Raught
Christopher B. Marshall
Michael Ohh
Mitsuhiko Ikura
author_facet Teklab Gebregiworgis
Yoshihito Kano
Jonathan St-Germain
Nikolina Radulovich
Molly L. Udaskin
Ahmet Mentes
Richard Huang
Betty P. K. Poon
Wenguang He
Ivette Valencia-Sama
Claire M. Robinson
Melissa Huestis
Jinmin Miao
Jen Jen Yeh
Zhong-Yin Zhang
Meredith S. Irwin
Jeffrey E. Lee
Ming-Sound Tsao
Brian Raught
Christopher B. Marshall
Michael Ohh
Mitsuhiko Ikura
author_sort Teklab Gebregiworgis
title The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
title_short The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
title_full The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
title_fullStr The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
title_full_unstemmed The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
title_sort q61h mutation decouples kras from upstream regulation and renders cancer cells resistant to shp2 inhibitors
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/adc5eaa39af340409424aef1fcf1144b
work_keys_str_mv AT teklabgebregiworgis theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT yoshihitokano theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jonathanstgermain theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT nikolinaradulovich theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT mollyludaskin theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT ahmetmentes theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT richardhuang theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT bettypkpoon theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT wenguanghe theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT ivettevalenciasama theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT clairemrobinson theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT melissahuestis theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jinminmiao theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jenjenyeh theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT zhongyinzhang theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT meredithsirwin theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jeffreyelee theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT mingsoundtsao theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT brianraught theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT christopherbmarshall theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT michaelohh theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT mitsuhikoikura theq61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT teklabgebregiworgis q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT yoshihitokano q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jonathanstgermain q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT nikolinaradulovich q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT mollyludaskin q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT ahmetmentes q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT richardhuang q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT bettypkpoon q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT wenguanghe q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT ivettevalenciasama q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT clairemrobinson q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT melissahuestis q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jinminmiao q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jenjenyeh q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT zhongyinzhang q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT meredithsirwin q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT jeffreyelee q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT mingsoundtsao q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT brianraught q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT christopherbmarshall q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT michaelohh q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
AT mitsuhikoikura q61hmutationdecoupleskrasfromupstreamregulationandrenderscancercellsresistanttoshp2inhibitors
_version_ 1718442365544300544